These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Type 2 diabetes mellitus and coronary heart disease]. Brändle M, Amann FW, Salomon F. Schweiz Med Wochenschr; 1999 May 08; 129(18):700-6. PubMed ID: 10407943 [Abstract] [Full Text] [Related]
3. Cardiovascular disease and intensive glucose lowering in type 2 diabetes. Younis N, Soran H, Hassanein M. QJM; 2009 Apr 08; 102(4):293-6. PubMed ID: 19147659 [No Abstract] [Full Text] [Related]
4. Glucose-lowering therapy after myocardial infarction: more questions than answers. Radke PW, Schunkert H. Eur Heart J; 2008 Jan 08; 29(2):141-3. PubMed ID: 18199566 [Abstract] [Full Text] [Related]
5. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials. Lamanna C, Monami M, Marchionni N, Mannucci E. Diabetes Obes Metab; 2011 Mar 08; 13(3):221-8. PubMed ID: 21205121 [Abstract] [Full Text] [Related]
6. Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS). Zhao SP, Lu ZL, Du BM, Chen Z, Wu YF, Yu XH, Zhao YC, Liu L, Ye HJ, Wu ZH, China Coronary Secondary Prevention Study (CCSPS). J Cardiovasc Pharmacol; 2007 Feb 08; 49(2):81-4. PubMed ID: 17312447 [Abstract] [Full Text] [Related]
10. Primary prevention of cardiovascular disease in people with dysglycemia. Bianchi C, Miccoli R, Penno G, Del Prato S. Diabetes Care; 2008 Feb 08; 31 Suppl 2():S208-14. PubMed ID: 18227487 [Abstract] [Full Text] [Related]
11. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Diabetes Care; 2007 Feb 08; 30(2):292-9. PubMed ID: 17259497 [Abstract] [Full Text] [Related]
16. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome. Linnemann B, Voigt W, Nobel W, Janka HU. Exp Clin Endocrinol Diabetes; 2006 Mar 08; 114(3):127-34. PubMed ID: 16636979 [Abstract] [Full Text] [Related]
17. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. N Engl J Med; 1998 Jul 23; 339(4):229-34. PubMed ID: 9673301 [Abstract] [Full Text] [Related]
18. The effectiveness and cost of single and multi-factorial cardiovascular risk factor modification to guideline targets in type 2 diabetes. Prescott A, Bailey JE, Kelly KJ, Munyombwe T, Gray A, Summers LK. Prim Care Diabetes; 2012 Apr 23; 6(1):67-73. PubMed ID: 22225755 [Abstract] [Full Text] [Related]
19. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Schramm TK, Gislason GH, Vaag A, Rasmussen JN, Folke F, Hansen ML, Fosbøl EL, Køber L, Norgaard ML, Madsen M, Hansen PR, Torp-Pedersen C. Eur Heart J; 2011 Aug 23; 32(15):1900-8. PubMed ID: 21471135 [Abstract] [Full Text] [Related]